Vivesto AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand in 1999 and is headquartered in Solna, Sweden.
Sector:
Health Technology
Industry:
Pharmaceuticals Generic
Employees:
4
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Vivesto AB - ADR market cap is $36,900.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Vivesto AB - ADR 52 week high is $0.02 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Vivesto AB - ADR 52 week low is $0.0001 as of November 22, 2026.
Vivesto AB - ADR stock price today is $0.0001.
Vivesto AB - ADR stock price yesterday was $0.0001.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Vivesto AB - ADR's P/E ratio is -0.01.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Vivesto AB - ADR P/B ratio is 0.0015.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Vivesto AB - ADR 50-day moving average is $0.0001.